Try our Advanced Search for more refined results

Nolte et al v. AbbVie, Inc. et al

  1. January 26, 2018

    AbbVie Drug Did Not Cause Man's Blood Clots, Jury Finds

    An Illinois federal jury on Friday rejected an Arizona man's claims that AbbVie Inc.’s AndroGel caused his pulmonary embolism, handing a win to AbbVie in its third bellwether trial in the multidistrict litigation over testosterone replacement therapy drugs.

  2. January 17, 2018

    AndroGel Can Cause Blood Clots Many Ways, Doc Tells Jury

    AndroGel and other testosterone replacement therapy drugs increase the risk of dangerous blood clots in men who use them, a Yale School of Medicine physician testifying for an AndroGel user suing AbbVie Inc. told an Illinois federal jury Wednesday.

  3. January 08, 2018

    Docs Weren't Warned About AndroGel's Risks, Jury Told

    The label on AbbVie Inc.'s AndroGel misled doctors about the drug's dangers, counsel for a man who suffered clots in his lungs while using the testosterone replacement therapy product told an Illinois federal jury Monday.

  4. January 05, 2018

    AbbVie Faces Third Jury In Testosterone MDL

    AbbVie will defend its product AndroGel for the third time Monday against claims it seriously injured one of its users as the company takes on the latest bellwether in multidistrict litigation over testosterone replacement therapy drugs in Illinois federal court.